[Improvement of flow properties of blood: a new principle for drug therapy of chronic peripheral arterial vascular disorders].
D000818:Animals; D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D001809:Blood Viscosity / Q000187:drug effects; D002908:Chronic Disease; D004912:Erythrocytes / Q000187:drug effects; D005121:Extremities / Q000098:blood supply; D005340:Fibrinogen; D006801:Humans; D010447:Peptide Hydrolases / Q000627:therapeutic use*; D012911:Snakes; D013300:Streptokinase / Q000627:therapeutic use; D014688:Venoms / Q000627:therapeutic use
D000933:Antifibrinolytic Agents; D014688:Venoms; D005340:Fibrinogen; D010447:Peptide Hydrolases; D013300:Streptokinase
Verbesserung der Fliesseigenschaften des Blutes: Ein neues Prinzip zur medikamentösen Therapie chronischer peripherer arterieller Durchblutungsstörungen.